NATCOPHARM stock
NATCOPHARM is in a mixed news setup around Pharmaceuticals; 4 recent stories are active but the saved quote move at +0.12% keeps the read balanced.
NATCOPHARM has built a mixed coverage cluster in the last 30 days. The strongest recurring theme is Pharmaceuticals, while the current weighted impact score is +3 from 1 bullish, 1 bearish, and 2 neutral stories across 2 sources.
NATCOPHARM is last saved at ₹841.05 with a day move of +0.12%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
NATCOPHARM has filed its latest quarterly results. The company reported revenues of Rs 474.8 crore and a profit of Rs 132.4 crore. This filing is on record and shows the company's financial performance for the quarter. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Economic Times · 12 days ago · 2 min read
Economic Times · 17 days ago · 2 min read
Mint · 26 days ago · 2 min read
Economic Times · 20 Jul 2026 · 2 min read
Economic Times · 19 Jul 2026 · 2 min read
How NATCOPHARM stacks against related names in this news cluster
NATCOPHARM has appeared across 4 recent stories from 2 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
NATCOPHARM coverage is currently mixed, with 1 bullish, 1 bearish, and 2 neutral analyzed stories in the recent window.
Recent NATCOPHARM coverage is clustering around Pharmaceuticals and Defence. Related names showing up alongside NATCOPHARM include ALEMBICPHAR, AUROPHARMA, CIPLA.
Use this page as a coverage hub for NATCOPHARM: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
3 recent mentions linked to NATCOPHARM
TopicDefence1 recent mentions linked to NATCOPHARM
StockALEMBICPHARRelated news cluster with 1 links
Latest storyDividend Alert: MAZAGONDOCK, NATCOPHARM Last Day to Buy for PayoutsThe pharmaceutical sector, represented by Natco Pharma and Marksans Pharma, continues to be influenc
How retail crowds and channels are talking about NATCOPHARM right now — context for your own research, not a trade call.